Nitrosatable Drug Exposure during Pregnancy and Preterm and Small-for-Gestational-Age Births | Academic Article individual record
abstract

BACKGROUND: Nitrosatable drugs react with nitrite in the stomach to form N-nitroso compounds, observed in animal models to result in adverse pregnancy outcomes, such as birth defects and reduced fetal weight. Previous studies examining prenatal exposure to medications classified as nitrosatable have reported an increased risk of preterm births (PTBs) and small-for-gestational-age (SGA) infants. METHODS: Using data from mothers (controls) of babies without major birth defects from the National Birth Defects Prevention Study, prenatal nitrosatable drug usage by trimester and month of gestation was examined in relation to PTBs and SGA infants. RESULTS: Positive associations were observed with nitrosatable drug use and PTBs, with the strongest relationship with second trimester exposure (adjusted hazard ratio [aHR] 1.37, [95% confidence interval (CI) 1.10, 1.70]). Of the nitrosatable functional groups, secondary amines were the most notable, with a higher association among women with second (aHR 1.37, [95% CI 1.05, 1.79]) and third (aHR 1.34, [95% CI 1.02, 1.76]) trimester exposure compared with women with no prenatal nitrosatable drug use. Among SGA infants, a borderline association was noted with amide exposure during the third trimester (adjusted odds ratio 1.43 [95% confidence interval [CI] 1.00, 2.05]). CONCLUSIONS: Prenatal exposure to nitrosatable drugs during the second and third trimester of pregnancy, particularly secondary amines, might increase the risk of PTBs. However, prenatal exposure to nitrosatable drugs was not associated with SGA infants, with the exception of amide drugs.

author list (cited authors)
Vuong, A. M., Shinde, M. U., Brender, J. D., Shipp, E. M., Jr, H., Zheng, Q. i., ... Stud, N.
publication date
2015
publisher
Wiley Publisher
published in
keywords
  • National Birth Defects Prevention StudyAdolescentAdultAmidesAminesAscorbic AcidCase-Control StudiesDietary SupplementsFemaleHumansInfant, NewbornInfant, Small For Gestational AgeMalePregnancyPregnancy TrimestersPremature BirthRisk FactorsUnited StatesYoung AdultNitrosatable DrugPreterm BirthSmall For Gestational AgeAdverse Pregnancy OutcomesVitamin C